HUM-MOLGEN events: Neurodegenerative Diseases: Biology & Therapeutics

A primary goal of the meeting is to provide a forum where medical scientists from academia can interact with scientists from the biopharmaceutical industry, thus forging a community of academic and industry researchers who recognize that they have much to learn from each other. Rational drug discovery for neurodegenerative diseases has begun to yield compounds and treatments that are now entering clinical settings. For human studies utilizing these compounds and treatments to be maximally informative, it is crucial that scientists from academia and industry meet regularly to exchange data and ideas.

This meeting will consist of six to seven oral sessions plus one poster session. The aim is to populate half of each oral session with speakers from academia and the other half from industry; speakers will be invited as well as selected from submitted abstracts.

Tentative Topics:

Propagation of Neurodegenerative Disease
Network Mechanisms of Neurodegenerative Disease
Neuroinflammation & Glial Biology of Neurodegeneration
ApoE and Lipid Metabolism
RNA Metabolism in Neurodegenerative Disease
The Endolysosome, Autophagy and Other Targets in Therapeutics

Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentations will be made by the organizers and individual session chairs. The status of abstracts (i.e., talk or poster) will be posted as soon as decisions have been made by the organizers. Please bring this announcement to the attention of any of your colleagues who may be interested in participating in the meeting.

We look forward to seeing you at Cold Spring Harbor Laboratory at the end of November 2018.